Abstract
Introduction: This study aimed to develop valid and reliable scale with the intention of measure Coping Self-efficacy (CSES) of Iranian type 2 diabetic patients. Patients and Methods: Validity and reliability of Iranian version of Coping Self-efficacy Scale (CSES) were measured by a cross-sectional study. Content validity, reliability and cultural equivalency were appraised through qualitative and quantitative study on 260 participants who have type 2 diabetes. Results: Reliability and validity of the scale and its four subscales, such as “stop unpleasant emotions and thoughts” (a = 0.92) “used problem-focused coping” (a = 0.71), Self-efficacy on diabetes problem solving (a = 0.74) and “get support from friends and family” (a = 0.67) were approved explicitly by a psychometric analysis; these show that the scale was slightly valid and reliable on the study setting. An intraclass correlation coefficient was satisfactory (p < 0.001). Criterion validity between total scale and metabolic control Index (HbA1c) of type 2 diabetic patients was significant (p < 0.001) and showed indirect correlation with the domains of the scale. Conclusion: Study findings supported the reliability and validity of the Iranian version of new Coping Self-efficacy-24 for measuring Coping Selfefficacy among Iranian type 2 diabetic patients. Based on our finding, we would like to recommend appropriate interventions in the future.
Highlights
This study aimed to develop valid and reliable scale with the intention of measure Coping Self-efficacy (CSES) of Iranian type 2 diabetic patients
As type 2 diabetes and its control are a big challenge among patients in their lives, we aimed to develop a valid and reliable scale with the intention of measuring Coping Self-efficacy (CSES) level of Iranian type 2 diabetes patients
Translated F-Coping Self-efficacy Scale (CSES)-26 was sent to 10 academic members who were expert in instrument development and type 2 diabetes management
Summary
This study aimed to develop valid and reliable scale with the intention of measure Coping Self-efficacy (CSES) of Iranian type 2 diabetic patients. There are studies which represented decreasing diabetes stress can be practical with using coping strategies [11] Since, it seems that coping Self-efficacy can be one of the main points of diabetes care because of rapid prevalence and incidence of diabetes in Iran [4], a great need for a valid and reliable scale for assessing psychosocial issues and interventional studies as Chesney et al mentioned it as a specific character of the scale. As type 2 diabetes and its control are a big challenge among patients in their lives, we aimed to develop a valid and reliable scale with the intention of measuring Coping Self-efficacy (CSES) level of Iranian type 2 diabetes patients. Validation of scale which was developed by Chesney et al (2006) seems to be a requisite in Iranian setup to conduct future interventions
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have